𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recent progress in the development of coumarin derivatives as potent anti-HIV agents

✍ Scribed by Donglei Yu; Madoka Suzuki; Lan Xie; Susan L. Morris-Natschke; Kuo-Hsiung Lee


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
318 KB
Volume
23
Category
Article
ISSN
0198-6325

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Numerous plant‐derived compounds have been evaluated for inhibitory effects against HIV replication, and some coumarins have been found to inhibit different stages in the HIV replication cycle. This review article describes recent progress in the discovery, structure modification, and structure–activity relationship studies of potent anti‐HIV coumarin derivatives. A dicamphanoyl‐khellactone (DCK) analog, which was discovered and developed in our laboratory, and calanolide A are currently in preclinical studies and clinical trials, respectively. © 2003 Wiley Periodicals, Inc. Med Res Rev, 23, No. 3, 322‐345, 2003


📜 SIMILAR VOLUMES


Synthesis and Studies of New 2-(Coumarin
✍ Dharmesh H. Mahajan; Christophe Pannecouque; Erik De Clercq; Kishor H. Chikhalia 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 483 KB 👁 2 views

## Abstract Novel 2‐(coumarin‐4‐yloxy)‐4,6‐(substituted)‐s‐triazine derivatives __i. e.,__ diaryltriazine (DATA) are reported as novel non‐nucleoside reverse transcriptase inhibitors (NNRTIs), were synthesized and their activities against human immunodeficiency virus HIV‐1 (III‐B), HIV‐2 (ROD), and